Saturday 17 October 2026
Export CLMT’s income statement to Excel — free account
Calumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024. In the quarter to June 2026, revenue grew 40.8%, EPS grew 35.9%, free cash flow grew 450.7% and total debt fell 1.98%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
57.75
0.49
−0.84%
Follow CLMT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 2 | 4 | 6 | 3 | 3 | 6 | 5 | 6 | 3 |
P/E ratio |
0.00 | 0.00 | 26.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
1.16 | 1.02 | — | — | — | — | — | — | — | — |
P/S ratio |
0.42 | 0.44 | 0.34 | 0.28 | 0.33 | 0.11 | 0.08 | 0.05 | 0.15 | 0.09 |
P/FCF ratio |
30.46 | 0.00 | 0.00 | 0.00 | 0.00 | 12.98 | 2.03 | 6.68 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(1.82) | (2.25) | — | — | — | — | — | — | — | — |
Beneish M-Score |
(2.96) | (2.22) | (2.48) | (3.01) | (2.42) | (2.06) | (3.03) | (3.04) | (2.10) | (3.05) |
P/Operating CF |
14.80 | (538.50) | (187.38) | (25.89) | (73.94) | (116.81) | 7.51 | 1.65 | (24.58) | 13.46 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.74 | 3.26 | 5.38 | 1.52 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.95 | 0.99 | 0.85 | 0.70 | 0.86 | 0.70 | 0.43 | 0.46 | 0.54 | 0.66 |
EV/EBITDA |
19.30 | 509.96 | 13.32 | 25.00 | 0.00 | 0.00 | 7.18 | 6.39 | 6.08 | 12.45 |
EV/Operating CF |
36.01 | (89.02) | (238.93) | 32.78 | (61.58) | 25.28 | 7.70 | 21.56 | (77.30) | 561.26 |
EV/FCF |
69.29 | (33.55) | (12.42) | (7.57) | (61.72) | 84.00 | 10.50 | 62.83 | (21.29) | (17.25) |
Quick Ratio |
0.52 | 0.38 | 0.26 | 0.22 | 0.32 | 0.50 | 0.37 | 0.85 | 0.94 | 0.42 |
Current Ratio |
1.02 | 0.89 | 0.71 | 0.61 | 0.70 | 0.98 | 0.91 | 1.61 | 1.29 | 1.29 |
Net Debt/EBITDA |
7.36 | 11.79 | 4.79 | 7.90 | 42.63 | 28.08 | 5.80 | 5.71 | 4.38 | 10.78 |
Debt/Assets |
89.36% | 85.04% | 78.61% | 74.28% | 80.13% | 80.28% | 65.20% | 76.86% | 74.10% | 73.29% |
Debt/Equity |
(3.28) | (3.29) | (4.41) | (3.82) | (4.43) | (11.29) | 56.08 | 24.42 | 16.62 | 9.13 |
Asset Turnover |
1.52 | 1.52 | 1.52 | 1.93 | 1.60 | 1.24 | 1.75 | 1.46 | 1.39 | 1.23 |
Operating CF/Net income |
(3.22) | 0.21 | (0.32) | (0.59) | 0.17 | (0.43) | (4.49) | (1.39) | 0.26 | (0.01) |
Capex/Depreciation |
(0.28) | (0.41) | (1.49) | (4.42) | 0.00 | (0.37) | (0.40) | (0.38) | (0.39) | (0.74) |
Interest Coverage |
0.50 | 0.03 | 1.21 | 0.75 | (0.57) | (0.57) | 0.57 | 0.79 | 0.86 | 0.00 |
| 4.68% | 36.89% | (9.19%) | 36.81% | 96.83% | 228.13% | (136.64%) | (67.92%) | (65.83%) | (82.64%) | |
| (1.24%) | (8.06%) | 1.72% | (6.97%) | (12.95%) | (7.96%) | (2.16%) | (2.26%) | (3.76%) | (11.36%) | |
ROIC |
4.64% | 0.32% | 10.03% | 5.62% | (4.17%) | (3.70%) | 3.93% | 5.07% | 6.18% | (0.01%) |
Return on Tangible Assets |
(2.47%) | (16.55%) | 3.96% | (17.86%) | (37.35%) | (16.04%) | (4.64%) | (3.99%) | (7.14%) | (18.14%) |
Average Days of Receivables |
20.51 | 24.23 | 24.99 | 20.80 | 29.33 | 25.81 | 19.93 | 20.66 | 34.34 | 21.53 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
4.15% | 4.80% | 4.49% | 4.21% | 6.48% | 6.12% | 5.50% | 5.17% | 5.43% | 5.05% |
Intangible Assets out of Total Assets |
0.06 | 0.07 | 0.07 | 0.08 | 0.10 | 0.13 | 0.13 | 0.12 | 0.10 | 0.11 |
Share Based Compensation of Revenue |
(0.11%) | 0.35% | 0.35% | 0.37% | 1.61% | 0.24% | 0.17% | (0.03%) | 0.31% | 0.16% |
Graham Net Nets |
(1.49) | (1.48) | (1.74) | (1.89) | (1.80) | (5.72) | (4.64) | (7.85) | (2.41) | (6.05) |
Graham Number |
8.61 | 22.55 | 0.00 | 17.57 | 18.92 | 8.57 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1.96%) | (11.99%) | 3.83% | (12.48%) | (24.47%) | (59.42%) | (15.07%) | (31.22%) | (14.69%) | (104.75%) |
Free Cash Flow Yield |
3.28% | (6.72%) | (20.40%) | (33.57%) | (4.21%) | 7.70% | 49.29% | 14.98% | (16.87%) | (43.29%) |
Revenue per Share |
47.68 | 50.39 | 52.21 | 59.07 | 39.86 | 28.94 | 44.14 | 44.87 | 48.50 | 45.10 |
Operating CF per Share |
1.26 | (0.56) | (0.19) | 1.27 | (0.56) | 0.80 | 2.45 | 0.96 | (0.34) | 0.05 |
Capex per Share |
(0.60) | (0.92) | (3.39) | (6.76) | 0.00 | (0.56) | (0.65) | (0.63) | (0.90) | (1.78) |
Free Cash Flow per Share |
0.65 | (1.48) | (3.58) | (5.49) | (0.56) | 0.24 | 1.80 | 0.33 | (1.24) | (1.73) |
Cash per Share |
2.36 | 0.55 | 0.10 | 0.44 | 0.48 | 1.40 | 0.24 | 2.00 | 6.63 | 0.05 |
Shareholders Equity per Share |
(8.44) | (8.56) | (6.12) | (6.72) | (4.88) | (1.64) | 0.28 | 0.84 | 1.55 | 2.84 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(8.44) | (8.56) | (6.12) | (6.72) | (4.88) | (1.64) | 0.28 | 0.84 | 1.55 | 2.84 |
Free Cash Flow |
56.60 | (123.10) | (286.70) | (435.40) | (43.90) | 18.90 | 140.70 | 25.80 | (96.20) | (133.40) |
Working Capital |
17.10 | (97.60) | (318.00) | (531.30) | (267.20) | (9.60) | (52.90) | 254.90 | 265.80 | 142.70 |
Capital Expenditures |
(52.30) | (76.70) | (271.80) | (536.00) | 0.10 | (43.90) | (51.20) | (49.40) | (69.70) | (137.50) |
Net Current Asset Value |
(2,563.80) | (2,704.10) | (2,446.90) | (2,454.70) | (1,880.40) | (1,402.00) | (1,324.10) | (1,351.80) | (1,377.40) | (1,865.60) |
EV/EBIT |
36.08 | 509.97 | 13.32 | 25.00 | 0.00 | 0.00 | 19.37 | 13.19 | 12.96 | 0.00 |
Capex to Sales |
0.01 | 0.02 | 0.07 | 0.11 | 0.00 | 0.02 | 0.01 | 0.01 | 0.02 | 0.04 |
Price to Operating Income |
15.86 | 226.04 | 5.26 | 9.83 | 0.00 | 0.00 | 3.74 | 1.40 | 3.61 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.13 | 0.12 | 0.08 | 0.13 | 0.13 | 0.13 | 0.12 | 0.15 | 0.11 |
Cash ROIC |
3.02% | (7.33%) | (17.06%) | (28.31%) | (3.23%) | 1.32% | 11.24% | 1.41% | (3.66%) | (6.01%) |
Accounts Receivable Turnover |
16.20 | 14.85 | 15.11 | 18.02 | 15.23 | 13.00 | 17.87 | 12.67 | 13.47 | 16.72 |
Accounts Payable Turnover |
12.92 | 12.32 | 9.76 | 11.67 | 12.51 | 10.59 | 13.93 | 12.68 | 11.70 | 10.42 |
Inventory Turnover |
9.71 | 9.25 | 7.96 | 10.52 | 10.34 | 7.92 | 10.41 | 10.23 | 9.72 | 8.32 |
Average Days of Payables |
26.40 | 29.58 | 31.52 | 37.22 | 36.56 | 30.17 | 28.00 | 23.92 | 31.55 | 32.61 |
Days of Inventory on Hand |
36.13 | 38.38 | 43.01 | 41.91 | 39.67 | 42.89 | 35.59 | 33.88 | 35.14 | 42.29 |
Average Receivables |
255.30 | 282.15 | 276.65 | 260.05 | 206.70 | 174.45 | 193.25 | 276.05 | 279.50 | 207.80 |
Average Payables |
301.15 | 321.40 | 382.00 | 371.50 | 240.15 | 204.75 | 215.40 | 241.45 | 279.10 | 296.25 |
Average Inventory |
400.75 | 427.85 | 468.55 | 412.15 | 290.75 | 273.75 | 288.35 | 299.25 | 336.10 | 371.10 |
Average Assets |
2,723.55 | 2,754.75 | 2,746.15 | 2,434.45 | 1,968.10 | 1,833.05 | 1,972.65 | 2,388.15 | 2,707.00 | 2,834.95 |
Average Common Equity |
(722.30) | (601.75) | (512.60) | (461.25) | (263.25) | (64.00) | 31.25 | 79.50 | 154.50 | 389.65 |
Columns are period end dates